Keith M Dawson
4PUBLICATIONS
65CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 17, 2024
A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma.Stefan Knop, Monika Szarejko, Norbert Grząśko
|Apr 29, 2024
The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell-Mediated Killing of AML Leukemic Stem Cells.Matteo Bianchi, Christian Reichen, Amelie Croset
|Nov 04, 2022
A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Prior Trastuzumab and Pertuzumab.Stefanie Fischer, Thorsten O Götze, Aurelius Omlin
|Jul 21, 2022
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants.Sylvia Rothenberger, Daniel L Hurdiss, Marcel Walser
Pageof 1
Frequent Collaborators
2 joint publications
Denis Villemagne
2 joint publications
Michael T Stumpp
1 joint publications
Sylvia Rothenberger
1 joint publications
Nicole Liechti
1 joint publications
Heyrhyoung Lyoo
1 joint publications
H Kaspar Binz
1 joint publications
Sabrina Lusvarghi
1 joint publications
Julia M Adler
1 joint publications
Judith Bushe
1 joint publications
Emanuel Wyler
